Treatment accuracy is achieved through daily 3D image guidance which ensures proper patient positioning and dose targeting even when anatomical changes occur. The system takes an image of the patient every day as part of the patient setup, enabling the clinical team to know exactly where the tumor is on that particular day.

The ultra-fast binary multileaf collimator, or MLC, is a key component of the System, enabling the System to deliver dose with extremely high precision and accuracy.


Continuous couch motion through the bore of the ring gantry facilitates seamless delivery to multiple targets or long volumes with no need for field matching, which would be required if using a conventional delivery device. This innovation in workflow also improves treatment quality by ensuring that highly-sculpted radiation doses can be delivered to tumors located anywhere in the body, regardless of the tumor size or the number of tumors receiving treatment.

A fully-integrated, simplified adaptive treatment planning solution, PreciseART™ Adaptive Radiation Therapy software, enables the clinical team to adjust therapy to changes in tumor size, shape and location — as well as subtle changes in the location of organs and other healthy tissue.

The PreciseRTX™ Retreatment Option makes it easier for clinicians to deliver precise doses of radiation in those cases where, unfortunately, cancer has recurred and retreatment with radiation is necessary.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

SOURCE Accuray Incorporated

Back to HCB News

Rad Oncology Homepage